Keflex (Cephalexin) Dosing for Uncomplicated UTI
For uncomplicated urinary tract infections in adults, the recommended dosing of Keflex (cephalexin) is 500 mg orally every 12 hours for 7-14 days. 1, 2, 3
Dosing Recommendations
- According to the FDA label, the usual adult dose for uncomplicated cystitis is 500 mg every 12 hours, with therapy continued for 7 to 14 days 1
- Recent evidence supports that twice-daily (BID) dosing is as effective as four-times-daily (QID) dosing for uncomplicated UTIs, with no significant difference in treatment failure rates (BID 12.7% vs QID 17%, p=0.343) 2
- A 2025 study comparing cephalexin 500 mg twice daily versus four times daily for UTIs diagnosed in the emergency department found no statistically significant difference in treatment failure rates (18.7% vs 15.0%, p=0.465) 3
Patient-Specific Considerations
- For more severe infections or those caused by less susceptible organisms, larger doses may be needed 1
- If daily doses greater than 4 g are required, parenteral cephalosporins should be considered 1
- Beta-lactams (including cephalexin) are generally considered alternative rather than first-line agents for uncomplicated UTIs due to:
Duration of Therapy
- Cystitis therapy with cephalexin should be continued for 7 to 14 days 1
- This duration is consistent with general recommendations for beta-lactam antibiotics in UTI treatment 4
Clinical Pearls and Caveats
- Beta-lactams like cephalexin should be used with caution for uncomplicated cystitis and considered alternative antimicrobials rather than first-line therapy 4
- Twice-daily dosing may improve patient adherence compared to four-times-daily dosing without compromising effectiveness 2, 3
- Local antimicrobial susceptibility patterns should be considered when selecting empiric therapy for UTIs 4
- For patients with complicated UTIs, treatment failure rates may be higher (27.3% with BID dosing vs 30.3% with QID dosing) 3
Alternative Regimens for Uncomplicated UTIs
First-line options (preferred over cephalexin) include:
Fluoroquinolones are highly efficacious but should be reserved for important uses other than acute cystitis due to their propensity for collateral damage 4